ImmunoCellular Therapeutics Ltd | D: Filing D
Sep 13, 2022 04:02
EOM Pharmaceutical Holdings | 4: Statement of changes in beneficial ownership of securities-Director Yu John S
Jun 9, 2018 04:07
EOM Pharmaceutical Holdings | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Mitchell P. Kopin(1.1%),Daniel B. Asher(1.1%), etc.
Feb 13, 2018 19:31
EOM Pharmaceutical Holdings | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Empery Asset Management, LP(0.38%),Ryan M. Lane(0.38%), etc.
Jan 17, 2018 01:47
EOM Pharmaceutical Holdings | SC 13G: Statement of acquisition of beneficial ownership by individuals
Jul 31, 2017 18:06
EOM Pharmaceutical Holdings | SC 13G: Statement of acquisition of beneficial ownership by individuals-Empery Asset Management, LP(9.99%),Ryan M. Lane(9.99%), etc.
Jul 20, 2017 00:07
EOM Pharmaceutical Holdings | 4: Statement of changes in beneficial ownership of securities-Director Gengos Andrew
Feb 14, 2017 05:04
EOM Pharmaceutical Holdings | 4: Statement of changes in beneficial ownership of securities-Director Yu John S
Jun 22, 2016 04:35
EOM Pharmaceutical Holdings | 4: Statement of changes in beneficial ownership of securities-Officer Titus Gary
Jun 22, 2016 04:34
EOM Pharmaceutical Holdings | 4: Statement of changes in beneficial ownership of securities-Director Singhvi Rahul
Jun 22, 2016 04:34
EOM Pharmaceutical Holdings | 4: Statement of changes in beneficial ownership of securities-Director SCHLOSSBERG MARK A
Jun 22, 2016 04:33
EOM Pharmaceutical Holdings | 4: Statement of changes in beneficial ownership of securities-Director LAPOINTE ANTHONY GREGG
Jun 22, 2016 04:32
No Data
No Data